HCPCS Level II code E1632 designates a wearable artificial kidney device intended for ambulatory or home-based renal replacement therapy. As wearable dialysis technology advances, E1632 has national relevance for device procurement, outpatient care models, and coverage policy for durable medical equipment. The code captures a novel class of renal replacement devices that may shift some dialysis care from in-center to wearable or home-managed settings.

Key payers included in national analyses are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for wearable renal replacement, coverage considerations by major payers, and benchmarking areas such as utilization, coding practice, and reimbursement policy. The publication highlights areas where payers may issue local coverage determinations, the potential billing pathways for device acquisition versus rental, and operational implications for outpatient dialysis providers and home health programs.

This summary provides a concise reference for payers, provider billing teams, and health policy analysts seeking to understand the role of HCPCS Level II code E1632 in the evolving landscape of renal replacement therapy and durable medical equipment coverage.